These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 28703764)
21. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. Ozawa T; Toba K; Kato K; Minagawa S; Saigawa T; Hanawa H; Makiyama Y; Moriyama M; Honma K; Isoda M; Hasegawa G; Naito M; Takahashi M; Aizawa Y J Mol Cell Cardiol; 2006 May; 40(5):629-38. PubMed ID: 16603182 [TBL] [Abstract][Full Text] [Related]
22. Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor. Miller JL; Church TJ; Leonoudakis D; Lariosa-Willingham K; Frigon NL; Tettenborn CS; Spencer JR; Punnonen J Mol Pharmacol; 2015 Aug; 88(2):357-67. PubMed ID: 26018904 [TBL] [Abstract][Full Text] [Related]
23. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised? Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933 [TBL] [Abstract][Full Text] [Related]
24. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. Hardee ME; Cao Y; Fu P; Jiang X; Zhao Y; Rabbani ZN; Vujaskovic Z; Dewhirst MW; Arcasoy MO PLoS One; 2007 Jun; 2(6):e549. PubMed ID: 17579721 [TBL] [Abstract][Full Text] [Related]
25. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma. Ribatti D; Poliani PL; Longo V; Mangieri D; Nico B; Vacca A Histopathology; 2007 Apr; 50(5):636-41. PubMed ID: 17394500 [TBL] [Abstract][Full Text] [Related]
26. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940 [TBL] [Abstract][Full Text] [Related]
27. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors. Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826 [TBL] [Abstract][Full Text] [Related]
28. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Satoh K; Kagaya Y; Nakano M; Ito Y; Ohta J; Tada H; Karibe A; Minegishi N; Suzuki N; Yamamoto M; Ono M; Watanabe J; Shirato K; Ishii N; Sugamura K; Shimokawa H Circulation; 2006 Mar; 113(11):1442-50. PubMed ID: 16534010 [TBL] [Abstract][Full Text] [Related]
29. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin. Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043 [TBL] [Abstract][Full Text] [Related]
30. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma. Ribatti D; Marzullo A; Gentile A; Longo V; Nico B; Vacca A; Dammacco F Histopathology; 2007 Apr; 50(5):591-6. PubMed ID: 17394495 [TBL] [Abstract][Full Text] [Related]
31. New avenues of exploration for erythropoietin. Maiese K; Li F; Chong ZZ JAMA; 2005 Jan; 293(1):90-5. PubMed ID: 15632341 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074 [TBL] [Abstract][Full Text] [Related]
33. [Pleiotropic effects of erythropoietin]. Kes P; Basić-Jukić N; Furić-Cunko V Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551 [TBL] [Abstract][Full Text] [Related]
34. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240 [TBL] [Abstract][Full Text] [Related]
36. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia. Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705 [TBL] [Abstract][Full Text] [Related]
38. Erythropoietin: multiple physiological functions and regulation of biosynthesis. Sasaki R; Masuda S; Nagao M Biosci Biotechnol Biochem; 2000 Sep; 64(9):1775-93. PubMed ID: 11055378 [TBL] [Abstract][Full Text] [Related]
39. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR. McArthur GA; Longmore GD; Klingler K; Johnson GR Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257 [TBL] [Abstract][Full Text] [Related]
40. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer. Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]